Cystic Fibrosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children and adolescents; both gender; age between 6 and 18 years with a clinical diagnostic of cystic fibrosis
Exclusion criteria
Exclusion criteria: Presentation pulmonary deterioration ( FEV1 less than 50%), exacerbation (hospital admission or progressive decline in lung function with episodes of acute worsening of respiratory symptoms) within the last 6 weeks of study initiation, presenting cardiovascular, neuromuscular or osteoarticular disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased cardiorespiratory fitness in children and adolescents with cystic fibrosis, verified by the six-minute walk test (6MWT), based on the finding of a variation of at least 5% in pre and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find an increase in FEV1, verified by spirometry, from a variation of at least 5% in pre- and post-intervention measurements. ;Increased muscle strength of the lower and upper limbs, verified by the isokinetic evaluation and handgrip, from the finding of a variation of at least 20% in the pre and post-intervention measurements. | — |
Countries
Brazil
Contacts
Universidade Federal da Bahia